NORDIC BIOSCIENCE HOLDING A/S financials
NORDIC BIOSCIENCE HOLDING A/S
549300CD4NK2BVJ4VL20 | Line item | 2025 | 2024 |
|---|---|---|
| Income statement | ||
| Revenue | DKK 426.3M | DKK 527.4M |
| Gross profit | DKK 338.3M | DKK 457.0M |
| Other income | DKK 6.5M | DKK 8.4M |
| Administrative expenses | DKK 63.3M | DKK 69.7M |
| Finance costs | DKK 36.5M | DKK 4.0M |
| Profit before tax | DKK 80.5M | DKK 209.8M |
| Income tax expense | DKK 26.0M | DKK 39.0M |
| Profit for the year | DKK 54.5M | DKK 170.8M |
| — attributable to owners | DKK 54.5M | DKK 170.8M |
| — attributable to NCI | DKK 0 | DKK 0 |
| Total comprehensive income | DKK 56.8M | DKK 170.8M |
| Per share | ||
| Basic EPS | DKK 0.05 | DKK 0.16 |
| Diluted EPS | DKK 0.05 | DKK 0.16 |
| Free cash flow / share | DKK -0.06 | DKK 0.35 |
| Cash flow statement | ||
| Net cash from operating activities | -DKK 44.8M | DKK 379.9M |
| Income taxes paid | DKK 46.2M | DKK 8.7M |
| Net cash from investing activities | -DKK 24.1M | -DKK 3.9M |
| Purchase of PP&E (capex) | DKK 23.8M | DKK 2.6M |
| Net cash from financing activities | -DKK 223.4M | -DKK 3.3M |
| Dividends paid | DKK 220.0M | DKK 0 |
| Lease liability payments | DKK 537.0K | DKK 512.0K |
| Balance sheet | ||
| Total assets | DKK 426.1M | DKK 720.3M |
| Non-current assets | DKK 167.3M | DKK 147.0M |
| Current assets | DKK 258.8M | DKK 573.3M |
| Inventories | DKK 26.0M | DKK 19.9M |
| Trade & other receivables | DKK 27.7M | DKK 82.9M |
| Cash & equivalents | DKK 136.7M | DKK 455.4M |
| Total equity | DKK 71.2M | DKK 230.9M |
| Non-current liabilities | DKK 33.3M | DKK 40.6M |
| Lease liabilities (non-current) | DKK 2.0M | DKK 2.4M |
| Current liabilities | DKK 321.6M | DKK 448.7M |
| Lease liabilities (current) | DKK 563.0K | DKK 671.0K |
| Deferred tax liabilities | DKK 0 | DKK 1.2M |
| Derived metrics | ||
| Free cash flow | -DKK 68.6M | DKK 377.3M |
| Net margin | 12.8% | 32.4% |
| Return on equity | 76.6% | 74.0% |
| Cash conversion ratio | -0.82× | 2.22× |
| Capex coverage | -1.88× | 146.15× |
| Other reported items | ||
| Current Accruals and Current Deferred Income Including Current Contract Liabilities | DKK 6.9M | DKK 8.5M |
| Current Contract Assets | DKK 63.0M | DKK 13.4M |
| Current Contract Liabilities | DKK 213.4M | DKK 329.0M |
| Current Tax Liabilities Current | DKK 47.1M | DKK 65.6M |
| Deferred Tax Assets | DKK 73.7M | DKK 67.8M |
| Effect of Exchange Rate Changes On Cash and Cash Equivalents | -DKK 26.5M | DKK 764.0K |
| Equity and Liabilities | DKK 426.1M | DKK 720.3M |
| Finance Costs Paid Classified As Operating Activities | DKK 7.5M | DKK 4.0M |
| Finance Income | DKK 12.2M | DKK 16.1M |
| Finance Income Received Classified As Operating Activities | DKK 18.0M | DKK 10.7M |
| Fixtures and Fittings | DKK 8.5M | DKK 10.9M |
| Increase Decrease In Cash and Cash Equivalents | -DKK 292.3M | DKK 372.7M |
| Increase Decrease In Working Capital | DKK 127.1M | -DKK 156.0M |
| Increase Decrease Through Sharebased Payment Transactions | DKK 3.4M | DKK 16.1M |
| Intangible Assets Other Than Goodwill | DKK 930.0K | DKK 4.1M |
| Issued Capital | DKK 10.6M | DKK 10.6M |
| Land and Buildings | DKK 84.3M | DKK 64.3M |
| Liabilities | DKK 354.9M | DKK 489.4M |
| Other Adjustments For Noncash Items | DKK 63.4M | DKK 55.1M |
| Other Comprehensive Income | DKK 2.3M | -DKK 42.0K |
| Other Comprehensive Income Before Tax Exchange Differences On Translation | DKK 2.3M | -DKK 42.0K |
| Other Current Payables | DKK 24.2M | DKK 17.9M |
| Other Current Receivables | DKK 5.4M | DKK 1.6M |
| Other Expense By Function | DKK 88.0M | DKK 70.4M |
| Research and Development Expense | DKK 163.6M | DKK 190.7M |
| Reserve of Exchange Differences On Translation | DKK 6.0M | DKK 3.8M |
| Retained Earnings | DKK 54.5M | DKK 216.6M |
| Trade and Other Current Payables To Trade Suppliers | DKK 23.8M | DKK 24.2M |
Every line item above is a fact tagged in NORDIC BIOSCIENCE HOLDING A/S's annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (DKK), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.